The difficulty for foreign companies to acquire Chinese firms shows no sign of letting up in 2014, but the trend is offset by the record-setting year Chinese firms had when acquiring other, foreign firms.
Reports say Chinese buyouts of overseas companies hit a new high in 2013. The trend emerged as reports frequently highlight the growing obstacles foreign firms face when looking to do business in China: lengthy merger reviews, strict regulators and industry crackdowns.
According to reports, telecommunications, Internet and media industries are the most difficult in which to do business for overseas companies. But others, including the food industry, have their own barriers; the 2011 buyout of China-based Yinlu Foods Group by Nestle took seven months to complete.
That is compared with China’s Shuanghui International Holdings’ buyout of Smithfield Foods last year, which cleared US review within four months.
Further, reports contrast M&A numbers of inbound and outbound M&A activity. Outbound deals reached a value of $68.7 billion last year, while inbound deals dropped to 540 transactions in the same timeframe – down from 831 the year before.
Full Content: Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Rumble Adds David Boies to Legal Team in $2 Billion Antitrust Battle with Google
May 14, 2025 by
CPI
China Summons Delivery Giants Over Unfair Competition Concerns
May 13, 2025 by
CPI
Judge Orders Sanctions Against Missouri for Noncompliance in Price-Fixing Probe
May 13, 2025 by
CPI
Confusion Reigns In AI Policy In US and Europe
May 13, 2025 by
CPI
EU Clears ADNOC’s $16.3 Billion Acquisition of Covestro
May 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas